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   A 24－year old man with the chief complaint of total urinary retention was referred to our hospital
in April， 1980． Physical examination revealed a tumor in the left lobe of the prostate． Prostatic
needle biopsy showed spindle cell sarcoma． One course of cyvadic－therapy was given preoperatively
and the tumor was moderately reduced in size． Total cystoprostatectomy with pelvic lymph ade－
nectomy was performed on June 4th， 1980． HistQlogical findings of the tumor revealed malignant
mesenchyoma and no lymph nodes metastases were found． After the operation， 1 course of cyvadic
regimen was given but， 9 months after the operation， lower abdominal tumor was palpable and a
cytology of the tumor showed local recurrence・of the disease． Thc patient underwent operation
（removal of tumor and rectosigmoid colon， colostomy）． Then the pelvic mass was irradiated （a total
of 4130 rads）． Third course of cyvadic regimen was given， but the lower abdominal mass continued
to enlarge． The patient died in July， 1981， a year and 3 months after the appearance of the first symp－
tom and工year and l month after cystoprostatectomy． At autopsy， a local recurrent tumor of l 1×
7×7 cm was found in the pelvic cavity． Multiple small （1 cm） metastases were found in the lung
but no lymph nodes metastasis was identified． Thirty－two Japanese cases of prostatic sarcoma during
the last 8 years are reviewed．



















































Fig． 1． Retrograde urethrocystography： The
    prostatic urethra was displaced to
    the right by the prostatic tumor．
Fig． 2－a．Before CYVADIC－therapy： CT－scan showed 8．5×6cm
mass in the left lobe of the prostate．
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Fig． 2－b．3 weeks after CYVADIC－therapy： The tumor was
reduced in size 6．1×5．7cm．
Table 1． Modified－CYVADIC regimen
1） Cyclophosphamide   2120mg／m ＃2－7TD p．o．
2） Vincristine lsmg／m2 x 2／3 ＃1， 5TD i．v．
3） Adriamycin 40mg／m2 x 2／3 ＃8TD i．v．











































600 泌尿紀要 28巻 5号 1982年
Fig． 3． Most of tumor component were small
    spindle blastomatoid cel！s and myoblas－
    tic cells， giant cells， cartilage were
    also indentified． Histopathological di－





























































































Svrgical precedure ＆ prognosis
Alive
Ho． of Free of evidence of Lo［al VnknownCases disease disease Dend Recurrence stetus
1） Pelvic
exenetration ］
2） Tetal cysto－prostatectomy 10









Alive： No evidence of disease





































療法）では， complete remission l4％， complete or
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